Shanghai Medical and Pharmaceutical Journal 2009 Issue 2 The publication policy presented by Prof Zhang Yongxin ,our editor-in-chief

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Shanghai Medical and Pharmaceutical Journal
1006-1533
2009 Issue 2

The publication policy presented by Prof Zhang Yongxin ,our editor-in-chief
xiao li

..............page:53-54

Facing serious and complicated economic situation at home and abroad,we must act proactively, overcome any obstacles, make new contributions, and achieve new development
Chen Tonghui

..............page:54-57

fa zhan she qu yi liao zhong zai ti zhi gai ge he ji zhi chuang xin
tang ying ; xie jian min

..............page:58-60

The clinical vicissitudes of infectious endocarditis
Yuan Yonggang;Zhou Daxin

..............page:61-64

a si pi lin de yan jiu jin zhan
zou kai hua ; zhang hua

..............page:64-66

Research progress on medicinal use of Duchesnea indica (Andr.)Focke
Wang Haiying;Zhang Cui

..............page:67-69

Questions and answers on diaognose and medical treatment of infectious endocarditis
Editorial Department

..............page:70

Clinical analysis of 176 cases of infectious endocarditis
Yang Kai;Zhou Daxin

..............page:71-73

Expression and clinical significance of Raf- 1 protein kinase and VEGF in colorectal adenoma
Li Jie;Chen Weichang;Tu Huiming

..............page:73-75

Identification of legal liability induced by adverse drug reaction and discussion about relief system
Yao Yu

..............page:76-78

The status of unsafe drug use by community residents and strategy for integrated pharmaceutical care in communities
Li Zhen;Fang Zongjun;Ge Mingjian

..............page:79-80

jie zhu zhuan jia li liang , yi yao wei zhong xin , geng chong fen di fa hui shang hai yi yao de qiao liang zuo yong shang hai yi yao zhao kai jiu jie yi ci bian wei hui yi
hu bao jia

..............page:90

A novel anti -osteoporosis agent zoledronic acid and its clinical status
Ma Peiqi

..............page:88-89

New drugs approved during 2008 and hopefully approved in 2009 in the worldwide market
Huang Shengyan

..............page:84-87

2009 nian kua guo yao qi zhong dian yan fa chan pin
zhong xun

..............page:82-83

yao xue fu wu shi yao pin jing ying qi ye can yu jing zheng de zui you li wu qi
le yun chang

..............page:81-82